Sees FY25 Adjusted EBITDA $310M-$340M. Sees FY25 R&D Expenses $305M-$335M; and SG&A Expenses $655M-$685M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS: